Related Experiment Video
Updated: May 29, 2025
09:14
Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
Published on: September 28, 2022
3.6K
Metabolic Reprogramming in Epstein-Barr Virus Associated Diseases.
Tiffany Melanie Yee1, Liang Wei Wang1
1Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore.
Journal of Medical Virology
|February 3, 2025
Summary
Epstein-Barr virus (EBV) manipulates host metabolism for its survival and spread. This review explores how viral factors rewire cellular metabolism, impacting disease and offering new research avenues in EBV metabolism.
Area of Science:
- Virology
- Molecular Biology
- Metabolic Regulation
Background:
- Epstein-Barr virus (EBV) is the first identified human cancer-causing virus.
- EBV is linked to cancers, autoimmune diseases, and hyperinflammatory disorders.
- Viral success relies on factors like EBV nuclear antigens, latent membrane proteins, and noncoding RNAs.
Purpose of the Study:
- To systematically review how EBV-encoded factors regulate host cell metabolism.
- To elucidate the mechanisms of metabolic rewiring driven by EBV.
- To identify future research directions in EBV-driven metabolism.
Main Methods:
- This is a review article, synthesizing existing research.
- It focuses on the interplay between EBV factors and host metabolic regulators.
- Key regulators discussed include mTOR, MYC, and HIF.
Main Results:
- EBV subverts host metabolic regulators (mTOR, MYC, HIF) for its lifecycle.
- Viral factors orchestrate metabolic changes essential for cell transformation and immune evasion.
- Metabolic rewiring is crucial for EBV persistence and propagation.
Conclusions:
- Understanding EBV's metabolic manipulation is key to combating EBV-associated diseases.
- Targeting EBV-driven metabolic pathways presents potential therapeutic strategies.
- Further research is needed to fully unravel the complexities of EBV metabolism.
